Supercritical fluids division: the SuperCritical solutions to your critical problems. Our SuperCritical Fluids Research & Development Center (CDFSC) is a recent unit of Pierre Fabre Médicament, second independent pharmaceutical French laboratory.
This department has developed an extensive expertise in SuperCritical Fluids, focused on the development of innovative API formulations. At Pierre Fabre our main patented technologies are performed in a multi-purpose platform in compliance with cGMP, (recognized as a pharmaceutical establishment by French health authorities). Formulplex, Formuldisp, Formulcoat and Micro-Nano particle processes are used to improve bioavailability, solubility, or for taste-masking and particle design.
We propose our services to external partners (from start-up to multinational) in the medical or paramedical field and from the early stage of development to commercial scale.
Formulplex® is a novel patented formulation process in a supercritical medium complexation with cyclodextrin in a solid form. It permits enhancement of the apparent solubility of a poorly soluble drug.
Formulplex®'s key advantages
Formulplex® is considered as a first step of formulation process by health authorities and consequently permits new formulations of API's already marketed, generating intellectual property (Life Cycle Management). Formulplex® is also a single step process, solvent free scaling-up mastered, with a production yield of 100% using a reaction simple and reproducible.
Please refer to our latest whitepaper to see our results.
Formuldisp® is an innovative single step patented process using CO2 as medium to load an API in an excipient matrix.
Formuldisp®'s key advantages include:
Formuldisp® is a suitable formulation process for oral administration using GRAS (generally recognized as safe) polymer. Formuldisp® is a solvent free and low temperature process which permits a total and stable amorphisation with a 100% yield.
Please refer to our latest whitepaper to see our results.
Formulcoat® is an innovative patented coating process using lipidic agent and leading to a uniform and homogeneous layer without agglomeration.
Formulcoat® permits to coat very small particles (<50µm) without any use of organic solvent during the coating process and at room temperature, with a high productivity (60kg/h).
Please refer to our latest whitepaper to see our results.
Enhancing the dissolution rate by increasing the surface specific area of an API.
Two processes are performed:
Please refer to our latest whitepaper to see our results.
Recognized quality engagement
Applications area:
Pierre Fabre Medicament - Supercritical Fluids Division
16 Rue Jean Rostand
Gaillac
81603
France
Contact: M. Bernard Freiss
Tel: +33 563 81 24 50
Fax: +33 5 63 81 24 78
Email:
claudine.richaud@pierre-fabre.com
Email:
supercritical-solutions@pierre-fabre.com
URL:
www.pierre-fabre.com
URL:
www.supercritical-solutions.com